Welcome to our dedicated page for C1 Fund news (Ticker: CFND), a resource for investors and traders seeking the latest updates and insights on C1 Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect C1 Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of C1 Fund's position in the market.
C1 Fund (NYSE:CFND) has successfully completed its Initial Public Offering, raising $60 million through the sale of 6,000,000 common stock shares at $10.00 per share. The Fund, which began trading on the NYSE on August 7, 2025, focuses on investing in private digital assets services and blockchain technology companies.
Led by CEO Dr. Kidwai, C1 Fund aims to democratize access to early-stage digital assets innovators, focusing on companies developing disruptive technologies with significant commercial potential. The Benchmark Company served as the sole book-running manager, with SoFi Securities and China Renaissance Securities as co-managers.
C1 Fund (NYSE:CFND) has announced the pricing of its initial public offering, offering 6,000,000 common shares at $10.00 per share. The Fund has granted underwriters a 30-day option to purchase up to 900,000 additional shares to cover over-allotments.
Trading is expected to commence on August 7, 2025 on the NYSE, with the offering closing on August 8, 2025. The IPO is expected to raise net proceeds of approximately $55.1 million, potentially reaching $63.4 million if the over-allotment option is fully exercised. The Fund plans to complete its investment of the net proceeds within three months, with a maximum timeline of 12 months post-closing.
FAQ
What is the current stock price of C1 Fund (CFND)?
